sumigran 85 mg/500 mg capsula
farmindustria s.a. - sumatriptan; naproxeno de sodio; - capsula - por capsula - sumatriptán
dexpharm 8mg/2ml solucion inyectable
oqcorp sociedad anonima cerrada - oqcorp s.a.c. - droguerÍa - fosfato de dexametasona; - solucion inyectable - por mililitro - - dexametasona
dologesidol 275 mg + 300 mg tableta recubierta
drogueria inretail pharma s.a.c - naproxeno de sodio; paracetamol; - tableta recubierta - por tableta; paracetamol 300.000000 mg; naproxeno de sodio 275.000000 mg; - paracetamol, combinaciones excl. psicolÉpticos
kineret
swedish orphan biovitrum ab (publ) - anakinra - arthritis, rheumatoid; covid-19 virus infection - inmunosupresores - la artritis reumatoide (ar)kineret está indicado en adultos para el tratamiento de los signos y síntomas de la ar en combinación con metotrexato, con una respuesta inadecuada a metotrexato solo. covid-19kineret is indicated for the treatment of coronavirus disease 2019 (covid-19) in adult patients with pneumonia requiring supplemental oxygen (low- or high-flow oxygen) who are at risk of progressing to severe respiratory failure determined by plasma concentration of soluble urokinase plasminogen activator receptor (supar) ≥ 6 ng/ml. periodic fever syndromeskineret is indicated for the treatment of the following autoinflammatory periodic fever syndromes in adults, adolescents, children and infants aged 8 months and older with a body weight of 10 kg or above:cryopyrin-associated periodic syndromes (caps)kineret is indicated for the treatment of caps, including:neonatal-onset multisystem inflammatory disease (nomid) / chronic infantile neurological, cutaneous, articular syndrome (cinca)muckle-wells syndrome (mws)familial cold autoinflammatory syndrome (fcas)familial mediterranean fever (fmf)kineret is indicated for the treatment of familial mediterranean fever (fmf). kineret debe administrarse en combinación con colchicina, si es apropiado. still’s diseasekineret is indicated in adults, adolescents, children and infants aged 8 months and older with a body weight of 10 kg or above for the treatment of still’s disease, including systemic juvenile idiopathic arthritis (sjia) and adult-onset still’s disease (aosd), with active systemic features of moderate to high disease activity, or in patients with continued disease activity after treatment with non-steroidal anti-inflammatory drugs (nsaids) or glucocorticoids. kineret can be given as monotherapy or in combination with other anti-inflammatory drugs and disease-modifying antirheumatic drugs (dmards).
acido tranexamico zentiva 500 mg comprimidos recubiertos con pelicula efg
zentiva k.s. - tranexamico acido - comprimido recubierto con pelÍcula - 500 mg - tranexamico acido 500 mg - Ácido tranexámico
dioxaflex cb nf 50mg capsula blanda
laboratorios bago del peru s.a. - capsula blanda - por capsula - diclofenaco
urofast d 50mg + 100mg capsula
laboratorios quilla pharma peru s.a.c. - capsula - por capsula; diclofenaco de sodio 50.000000 mg; clorhidrato de fenazopiridina 100.000000 mg; - diclofenaco, combinaciones
neoparin (enoxaparina sodica) 10 mg / 0,1 ml solucion inyectable
hero pharma, c.a - enoxaparina sodica - solucion inyectable - 10 mg / 0,1 ml
diclo -k-100
laboratorios rowe s.r.l., república dominicana - diclofenaco potásico - comprimido recubierto - 100,0 mg
dipiridamol-25
empresa laboratorios medsol, la habana, cuba. - dipiridamol - tableta - 25 mg